| INTRODUC TI ON
Patent ductus arteriosus (PDA) is a significant challenge in preterm infants. This patency is related to higher rates of serious morbidities, including respiratory distress syndrome (RDS), bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), pulmonary hemorrhage, and mortality. 1 Despite the current debate regarding whether urgent closure is beneficial or not, pharmacological and/ or surgical intervention is still widely used in neonatal intensive care units. 2, 3 Although Doppler echocardiographic assessment is the principal method for diagnosis and follow-up, researchers continue to search for alternative tools for prediction of PDA and/or response to medical treatment.
The role of platelets in ductal closure became of interest following the results of an animal study. 4 Later, the association of PDA with platelet count and indices was investigated several times but with conflicting results. A recent meta-analysis by Simon et al 5 that
included 3479 preterm infants from 11 studies demonstrated that thrombocytopenia in early life was a modest but significant risk factor for persistent PDA. Also, in another meta-analysis, platelet count appeared lower in premature infants who did not respond to the first medical treatment. 6 In the following limited number of studies, the role of platelet indices in ductal patency was investigated, but no clear relationship was found. [7] [8] [9] [10] [11] There is also scant data regarding the value of plateletcrit (PCT) in PDA.
Red blood cell distribution width (RDW) is a parameter that measures the range of variation of red blood cell volume. The critical role of RDW has been revealed in a variety of inflammatory diseases in adults. [12] [13] [14] [15] [16] The normal ranges of RDW values were identified in neonates. 17, 18 It was shown that there was an inverse relationship between gestational age and RDW, but data on the association of RDW with neonatal morbidities are limited. Only one study inferred a correlation between high RDW and neonatal morbidities such as PDA and BPD. 19 The rise of PDA rates in the presence of chorioamnionitis or sepsis indicated the presence of inflammation in the etiology. This inflammatory state was speculated to raise RDW values.
Red cell distribution width-to-platelet ratio (RPR) is a quite new, easily calculated parameter that was demonstrated to have a high predictive value in inflammatory diseases of adults. [20] [21] [22] We hypothesized that this index may be supportive in the diagnosis of hemodynamically significant PDA (hsPDA) and prediction of ductal closure with pharmacotherapy, in addition to echocardiography.
Therefore, the aim of this study was to assess whether RPR would be useful in the diagnosis and follow-up of the response to treatment. Platelet count, indices, and RDW were acquired, and RPR was calculated from the samples. The formula of RDW-to-platelet ratio was used for the calculation. Sequential indices were compared between the groups and subgroups. or Mann-Whitney U test (for nonparametric continuous variables)
| ME THODS

| Statistical analysis
were used for univariate analysis. Statistical significance was set at P < 0.05. Multiple logistic regression analysis was performed to evaluate variables that were most probably associated with hsPDA.
Odds ratios and 95% confidence intervals were used in this analysis.
The cutoff for RPR values was calculated with a receiver operating characteristic curve. Multivariate analysis was performed to explore the individual effects of each variable on raising RPR above the cutoff value.
| RE SULTS
A total of 305 neonates, ≤32 weeks and ≤1500 g, were accepted
to the NICU during the study period. A total of 209 patients were evaluated for eligibility and 93 patients were excluded due to paracetamol administration (n = 31), sepsis (n = 30), nonsignificant PDA Table 1 . Gestational ages and birthweights of the neonates were 28 ± 2 weeks and 1207 ± 372 g in the study group and 29 ± 2 weeks and 1275 ± 218 g in the control group, respectively (P > 0.05; Table 1 ).
The comparison of hematological parameters between hsPDA and non-PDA infants is shown in Table 2 . PCT was lower in the hsPDA group as compared to non-PDA patients (0.185 ± 0.055 vs 0.214 ± 0.066, P = 0.025). While the RDW and platelet count was similar between groups, RPR was higher in the hsPDA group and the difference was statistically significant (0.084 ± 0.069 and 0.068 ± 0.024 in study and control groups, respectively; P < 0.01).
Hematological parameters were compared between responders and nonresponders (Table 3) vs 0.220 ± 0.095 in open and closed PDA groups respectively; P < 0.01).
ROC analysis was performed to evaluate the utility of RPR (Figure 1) . Cutoff values are demonstrated in Table 4 . A cutoff value of 0.13 showed 61% sensitivity and 92% specificity for the predic- 
| D ISCUSS I ON
Our aim was to evaluate the value of RPR in hsPDA diagnosis and prediction of ductal closure with medical treatment in preterm infants. This study revealed that RPR may be a supportive tool for both diagnosis and responsiveness to medical therapy. Also, high PCT was found to be associated with hsPDA and a worse response to medical therapy.
We found no association of platelet count with hsPDA or responsiveness to medical therapy. Despite the conflicting results of scientific articles, a recent meta-analysis showed that thrombocytopenia in early life was a moderate and significant risk factor for PDA in very preterm infants. We established that PCT was lower in both hsPDA and nonresponders with normal platelet counts. PCT, an indicator of platelet mass, is the volume occupied by platelets in the blood. PCT was detected to be low in nearly half of the patients, despite normal platelet count. 23 Tvedten et al 24 proposed the superiority of PCT rather than count in the evaluation of platelet status. This platelet index has been minimally searched and therefore undervalued in neonates.
Normative ranges were identified as 0.19 ± 0.05 in 30 preterm TA B L E 4 AUC, cutoff value, specificity, sensitivity, PPV, and NPV of RPR neonates, similar to our study, and additionally, a linear relationship between gestational age and PCT was demonstrated in the same study. 9 This may actually be related to morbidities of prematurity, not gestational age. The link between platelet mass and responsiveness to pharmacotherapy was investigated in a limited number of studies, but with conflicting results. The direct relationship between PDA and PCT has not been studied previously. We speculated that low PCT may reflect increased consumption and a defective role of platelets in ductal closure. Again, platelet volume deficiency may have inhibited the success of medical therapy.
The RDW values were similar in the groups and subgroups.
Yčas et al 25 put forward a hypothesis that acute hypoxia results in increased red blood cell size variability. Apart from the hypoxia, current studies indicate a link between high RDW and inflammation.
However, there is limited data regarding whether a similar relationship is present in critically ill neonates or not. Normative ranges were identified in both term and preterm infants, and an inverse link was shown between gestational age and RDW values. 17, 18 A correlation was demonstrated between high RDW and mortality in septic newborns. 22 Garofoli et al 19 showed that RDW had a prognostic role for neonatal morbidities, such as PDA and mortality, in preterm and IUGR infants. The speculation was that inflammation and hypoxia are involved in the pathogenesis of PDA.
A new index, namely RPR, which possesses a good predictive property for inflammatory liver and cardiac diseases in adults, was put forth. [20] [21] [22] General sterile inflammation was thought to have a part in PDA pathogenesis. 26 This systemic inflammation was overt during the first 3 days of life independent of sepsis, probably due to intensive care. 27 As a result of this inflammation, prostaglandin E2 and prostacyclin release, with stimulation of the cyclooxygenase pathway, have a substantial role in ductal patency. 27 This implication was supported by the claim that intrauterine inflammation, namely chorioamnionitis, was an independent risk factor for PDA.
28
Depending on the connection of high RDW and low platelet number to the presence of inflammation, we speculated that RPR may be a valuable index in hsPDA. We demonstrated a high predictive value of RPR both in diagnosis and for the unresponsive group to ibuprofen treatment.
To the best of our knowledge, this is the first study that has mentioned the RPR index in preterm infants. Moreover, the question is raised whether PCT may be a more valuable platelet index than previously thought. While several studies evaluated the hemogram parameters once in the first days of life, we further analyzed these values three times. We also attempted to determine the predictive value of these parameters and of RPR for both hsPDA diagnosis and the monitoring of ductal closure through sequential assessments. We excluded infants who were given paracetamol treatment due to debatable issues related to this therapy.
The reliability of the outcomes was enhanced using the same hematology counter in this period. However, the retrospective nature and modest sample size are limitations of this study. Although we excluded infants with a sepsis diagnosis, the general sick state or other accompanying morbidities of the newborns may have influenced the results. We are not able to claim that the parameters are solely linked with hsPDA. Future studies must focus on these confounding factors in prospectively randomized controlled studies in large-scale populations.
| CON CLUS ION
RPR may be a supportive tool in the both diagnosis and prediction of ductal closure in addition to Doppler echocardiography. The fact remains that this study may be a touchstone for future studies on the prognostic value of PCT and RPR in preterm infants.
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